Abstract:Objective To explore the prevalence of SLC25A13 gene mutations in Chinese infants with intrahepatic cholestasis and to understand the clinical presentation,laboratory biochemistry and blood amino acids features of patients with mutations.Methods Blood amino acids were analyzed by using mass chromatography in 115 infants who were referred to our hospital for further investigations of intrahepatic cholestasis from December 2003 to December 2006. All exons and their neighbouring sequences of SLC25A13 gene were analysed in children whose plasma citrulline obviously elevated. Two most common mutations of SLC25A13 gene, 851del4 and 1638ins23 were screened in children without obvious citrullinemia. Mutation 851del4 was detected by real-time fluorescent quantitation PCR with double labelling probes, and mutation 1638ins23 was detected by electrophoresis of PCR product directly. If the children in whom only one heterozygous mutation was found, all exons and nearby sequences were analysed then after. Clinical presentation,laboratory biochemistry and blood amino acids examinations were analyzed.Results SLC25A13 gene mutations were found in 4 of 5 children with citrullinemia, including 1 patient with homozygous mutation 851del4/851del4, 1 patient with compound heterozygous mutation 851del4/1638ins23, and 2 patients with heterozygous mutation 851del4. SLC25A13 gene mutations were also found in 6 cases of the other 110 intrahepatic cholestasis patients, including 1 patient with homozygous mutation 851del4/851del4, 1 patient with compound heterozygous mutation 851del4/1638ins23, and 4 patients with heterozygous mutation 851del4. Totally, SLC25A13 gene mutations were detected in 10 of the 115 intrahepatic cholestasis patients. The prevalence rate was 8.7%. Liver biopsy was done in 7 of 10 children with SLC25A13 gene mutations, and significant steatosis was found in 4 of them. Laboratory biochemistry changes included obviously elevation of bilirubin,γ-glutamyl transpeptidase and alkaline phosphatase. The elevation of aspartate aminotransferase was more obvious than alanine aminotransferase. Characteristic amino acids such as citrulin,threonine and methionine elevation was found in 5 children with mutations.Conclusions SLC25A13 gene mutation was one of the important causes of Chinese infantal intrahepatic cholestasis. Liver biopsy, laboratory biochemistry, and blood amino acids examination were important for the diagnosis of SLC25A13 gene mutations, however, the final diagnosis must rely on gene detection.

[Studies on the clinical manifestation and SLC25A13 gene mutation of Chinese patients with neonatal intrahepatic cholestasis caused by citrin deficiency].

Clinical and Genetic Analysis of 26 Chinese Patients with Neonatal Intrahepatic Cholestasis Due to Citrin Deficiency.

[Identification and Diagnosis of Three Novel Mutations in SLC25A13 Gene of Neonatal Intrahepatic Cholestasis Caused by Citrin Deficiency].

Neonatal Intrahepatic Cholestasis caused by Citrin Deficiency: In vivo and in vitro studies of the aberrant transcription arising from two novel splice-site variants in SLC25A13

[Analysis of clinical and genetic variation in neonatal intrahepatic cholestasis caused by citrin deficiency]

Clinical research of neonatal intrahepatic cholestasis caused by Citrin deficiency in Hubei Province

Clinical, Molecular and Functional Investigation on an Infant with Neonatal Intrahepatic Cholestasis Caused by Citrin Deficiency (NICCD).

Neonatal Intrahepatic Cholestasis Caused by Citrin Deficiency: Clinical and Laboratory Investigation of 13 Subjects in Mainland of China

The mutation spectrum of the SLC25A13 gene in Chinese infants with intrahepatic cholestasis and aminoacidemia

Novel mutations in the SLC25A13 gene in a patient with NICCD and severe manifestations.

SLC25A13 Gene Mutation Analysis in a Pedigree of Neonatal Intrahepatic Cholestasis Caused by Citrin Deficiency

Neonatal intrahepatic cholestasis caused by citrin deficiency: a clinicopathological analysis of two cases

SLC25A13 Gene Mutation in Infants with Intrahepatic Cholestasis

Molecular Diagnosis of Pediatric Patients with Citrin Deficiency in China: SLC25A13 Mutation Spectrum and the Geographic Distribution.

SLC25A13 Gene Analysis in Citrin Deficiency: Sixteen Novel Mutations in East Asian Patients, and the Mutation Distribution in a Large Pediatric Cohort in China

Molecular Diagnosis of Citrin Deficiency in an Infant with Intrahepatic Cholestasis: Identification of a 21.7kb Gross Deletion That Completely Silences the Transcriptional and Translational Expression of the Affected SLC25A13 Allele.

Analysis of SLC25A13 Gene Mutations and Prenatal Diagnosis for 20 Families Affected with Citrin Deficiency

Blood Glucose and Insulin and Correlation of SLC25A13 Mutations with Biochemical Changes in NICCD Patients.

Inspissated Bile Syndrome in an Infant with Citrin Deficiency and Congenital Anomalies of the Biliary Tract and Esophagus: Identification and Pathogenicity Analysis of a Novel SLC25A13 Mutation with Incomplete Penetrance.

[A difficult and complicated case study: neonatal intrahepatic cholestasis caused by citrin deficiency]

SLC25A13 Cdna Cloning Analysis Using Peripheral Blood Lymphocytes Facilitates the Identification of a Large Deletion Mutation: Molecular Diagnosis of an Infant with Neonatal Intrahepatic Cholestasis Caused by Citrin Deficiency.